Management of Capillaritis
The initial approach to capillaritis should focus on identifying and treating the underlying cause, with corticosteroids being the mainstay of treatment for most cases, particularly when associated with systemic vasculitis or collagen vascular diseases.
Types and Presentation
Capillaritis refers to inflammation of small blood vessels (capillaries) and can manifest in different forms:
Cutaneous capillaritis (pigmented purpuric dermatoses)
Pulmonary capillaritis
Rheumatoid capillaritis
- Cutaneous manifestation in patients with rheumatoid arthritis
- Related to disease activity rather than medications 5
Diagnostic Approach
Clinical evaluation
- Assess for systemic symptoms (respiratory, renal, joint involvement)
- Evaluate for upper and lower respiratory tract symptoms in suspected pulmonary capillaritis
- Examine for cutaneous manifestations
Laboratory testing
- Complete blood count
- Renal function tests
- Autoimmune serologies (ANCA, ANA, rheumatoid factor)
- Urinalysis to evaluate for glomerulonephritis
Imaging
- Chest radiograph for pulmonary involvement
- Consider MRI for deeper tissue involvement (as recommended for pyomyositis, which follows similar diagnostic principles) 6
Biopsy
- Skin or lung biopsy depending on the site of involvement
- Direct immunofluorescence studies to rule out immune complex deposition
Treatment Approach
For Cutaneous Capillaritis:
Mild cases:
Moderate to severe cases:
- Consider systemic corticosteroids (e.g., prednisone 40 mg daily for 7 days) in non-diabetic adult patients 6
For Pulmonary Capillaritis:
Acute management:
- Prompt respiratory support for patients with respiratory failure
- Mechanical ventilation may be required in severe cases 4
Immunosuppressive therapy:
- Corticosteroids (high-dose) as first-line treatment
- Cyclophosphamide or azathioprine as steroid-sparing agents 3
- Exclude infection before initiating immunosuppression
For cases with underlying systemic vasculitis:
- Treat according to the specific vasculitis protocol
- May require combination therapy with corticosteroids and immunosuppressants
Special Considerations
Recurrent disease:
- For patients with recurrent episodes (3-4 per year), consider prophylactic antibiotics such as oral penicillin or erythromycin twice daily for 4-52 weeks, or intramuscular benzathine penicillin every 2-4 weeks 6
Monitoring:
- Regular follow-up to assess response to treatment
- Monitor for development of systemic disease in isolated capillaritis
- Evaluate for medication side effects, particularly with long-term immunosuppression
Prognosis:
- Generally favorable for isolated pulmonary capillaritis 4
- Cutaneous forms are typically benign but may recur
Pitfalls and Caveats
Misdiagnosis risk:
- Cutaneous capillaritis can be misdiagnosed as other conditions that follow similar distribution patterns 2
- Pulmonary capillaritis must be distinguished from infectious causes of pulmonary hemorrhage
Treatment considerations:
- Exclude infection before initiating immunosuppression, as many of the treatments can worsen infectious processes 3
- Balance the risks of immunosuppression against the severity of disease
Follow-up importance:
- Even isolated capillaritis requires follow-up to monitor for development of systemic disease
- Some patients may experience multiple recurrences requiring ongoing therapy 4